Coopersurgical

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Details

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

4 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Regulatory

19822 events

FDAJan 1

Cu-7 — CU-7

Application NDA017408 (NDA)

FDAJan 1

Cu-7 — TATUM-T

Application NDA018205 (NDA)

19841 event

FDANov 15

Cu-7 — PARAGARD T 380A

Application NDA018680 (NDA)

20251 event

FDAFeb 24

Cu-7 — MIUDELLA

Application NDA218201 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)